CoChat
Sign Up
Cited by 39

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1

Hampton, Kaia K., Anderson, Katie, Frazier, Hilaree, Thibault, Olivier, Craven, Rolf J.·2018·Molecular Pharmacology
DOI 10.1124/mol.117.110510
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/mol.117.110510

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 56

  1. Ahmed, 2010, Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity, J Biol Chem, 285, 24775, 10.1074/jbc.M110.134585 · DOI
  2. Ahmed, 2010, Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule, J Pharmacol Exp Ther, 333, 564, 10.1124/jpet.109.164210 · DOI
  3. Aizen, 2015, Role of Pgrmc1 in estrogen maintenance of meiotic arrest in zebrafish oocytes through Gper/Egfr, J Endocrinol, 225, 59, 10.1530/JOE-14-0576 · DOI
  4. Alghamdi, 2014, A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes, Cell Signal, 26, 1355, 10.1016/j.cellsig.2014.02.015 · DOI · Paper page
  5. Bashour, 2012, Progesterone directly and rapidly inhibits GnRH neuronal activity via progesterone receptor membrane component 1, Endocrinology, 153, 4457, 10.1210/en.2012-1122 · DOI
  6. Belfiore, 2009, Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease, Endocr Rev, 30, 586, 10.1210/er.2008-0047 · DOI
  7. Boothe, 2016, Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells, Mol Metab, 5, 366, 10.1016/j.molmet.2016.01.009 · DOI
  8. Cahill, 2007, Progesterone receptor membrane component 1: an integrative review, J Steroid Biochem Mol Biol, 105, 16, 10.1016/j.jsbmb.2007.02.002 · DOI
  9. Chang, 2004, Insulin signaling and the regulation of glucose transport, Mol Med, 10, 65, 10.2119/2005-00029.Saltiel · DOI
  10. Crudden, 2005, Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors, Tumour Biol, 26, 142, 10.1159/000086485 · DOI
  11. de la Monte, 2012, Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease, Curr Alzheimer Res, 9, 35, 10.2174/156720512799015037 · DOI
  12. Elbein, 2011, Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI, Diabetes, 60, 1019, 10.2337/db10-1270 · DOI
  13. Forest, 2015, Intrinsic resistance to cixutumumab is conferred by distinct isoforms of the insulin receptor, Mol Cancer Res, 13, 1615, 10.1158/1541-7786.MCR-15-0279 · DOI
  14. Franks, 2016, BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549, BMC Res Notes, 9, 134, 10.1186/s13104-016-1919-4 · DOI
  15. Frasca, 1999, Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells, Mol Cell Biol, 19, 3278, 10.1128/MCB.19.5.3278 · DOI
  16. Giorgino, 1991, Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype, Mol Endocrinol, 5, 452, 10.1210/mend-5-3-452 · DOI
  17. Goh, 2013, Endocytosis of receptor tyrosine kinases, Cold Spring Harb Perspect Biol, 5, 10.1101/cshperspect.a017459 · DOI
  18. Guo, 2016, Progesterone receptor membrane component 1 mediates progesterone-induced suppression of oocyte meiotic prophase I and primordial folliculogenesis, Sci Rep, 6, 36869, 10.1038/srep36869 · DOI
  19. Hampton, 2014, Pathways driving the endocytosis of mutant and wild-type EGFR in cancer, Oncoscience, 1, 504, 10.18632/oncoscience.67 · DOI · Paper page
  20. Hand, 2003, Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor, Eukaryot Cell, 2, 306, 10.1128/EC.2.2.306-317.2003 · DOI
  21. Huang, 2007, The GLUT4 glucose transporter, Cell Metab, 5, 237, 10.1016/j.cmet.2007.03.006 · DOI
  22. Hughes, 2007, Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes, Cell Metab, 5, 143, 10.1016/j.cmet.2006.12.009 · DOI · Paper page
  23. Jones, 2014, The hexosamine biosynthesis pathway and O-GlcNAcylation maintain insulin-stimulated PI3K-PKB phosphorylation and tumour cell growth after short-term glucose deprivation, FEBS J, 281, 3591, 10.1111/febs.12879 · DOI
  24. Kabe, 2016, Haem-dependent dimerization of PGRMC1/sigma-2 receptor facilitates cancer proliferation and chemoresistance, Nat Commun, 7, 11030, 10.1038/ncomms11030 · DOI · Paper page
  25. Kishi, 2007, APS-mediated ubiquitination of the insulin receptor enhances its internalization, but does not induce its degradation, Endocr J, 54, 77, 10.1507/endocrj.K06-056 · DOI
  26. Kraft, 2015, Expression, purification, and functional characterization of the insulin-responsive facilitative glucose transporter GLUT4, Protein Sci, 24, 2008, 10.1002/pro.2812 · DOI
  27. Krebs, 2000, A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors, Proc Natl Acad Sci USA, 97, 12816, 10.1073/pnas.97.23.12816 · DOI
  28. Lodde, 2011, A novel role for progesterone and progesterone receptor membrane component 1 in regulating spindle microtubule stability during rat and human ovarian cell mitosis, Biol Reprod, 84, 715, 10.1095/biolreprod.110.088385 · DOI
  29. Malaguarnera, 2011, The insulin receptor: a new target for cancer therapy, Front Endocrinol (Lausanne), 2, 93, 10.3389/fendo.2011.00093 · DOI
  30. McClain, 1992, Mechanism and role of insulin receptor endocytosis, Am J Med Sci, 304, 192, 10.1097/00000441-199209000-00009 · DOI
  31. Mir, 2012, Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1, J Biol Chem, 287, 14494, 10.1074/jbc.M111.324921 · DOI
  32. Moller, 1989, Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man, Mol Endocrinol, 3, 1263, 10.1210/mend-3-8-1263 · DOI
  33. Morcavallo, 2014, Ligand-mediated endocytosis and trafficking of the insulin-like growth factor receptor I and insulin receptor modulate receptor function, Front Endocrinol (Lausanne), 5, 220, 10.3389/fendo.2014.00220 · DOI
  34. Morrione, 2000, Grb10 proteins in insulin-like growth factor and insulin receptor signaling (review), Int J Mol Med, 5, 151
  35. Mosthaf, 1990, Functionally distinct insulin receptors generated by tissue-specific alternative splicing, EMBO J, 9, 2409, 10.1002/j.1460-2075.1990.tb07416.x · DOI
  36. Nölte, 2000, Localization and topology of ratp28, a member of a novel family of putative steroid-binding proteins, Biochim Biophys Acta, 1543, 123, 10.1016/S0167-4838(00)00188-6 · DOI
  37. Oda, 2011, Progesterone receptor membrane component 1 modulates human cytochrome P450 activities in an isoform-dependent manner, Drug Metab Dispos, 39, 2057, 10.1124/dmd.111.040907 · DOI
  38. Pedersen, 2013, Protein kinase Cε modulates insulin receptor localization and trafficking in mouse embryonic fibroblasts, PLoS One, 8, 10.1371/journal.pone.0058046 · DOI
  39. Peluso, 2013, Progesterone receptor membrane component 1 and its role in ovarian follicle growth, Front Neurosci, 7, 99, 10.3389/fnins.2013.00099 · DOI
  40. Peluso, 2005, Expression and function of PAIRBP1 within gonadotropin-primed immature rat ovaries: PAIRBP1 regulation of granulosa and luteal cell viability, Biol Reprod, 73, 261, 10.1095/biolreprod.105.041061 · DOI
  41. Peluso, 2013, Plasminogen activator inhibitor 1 RNA-binding protein interacts with progesterone receptor membrane component 1 to regulate progesterone’s ability to maintain the viability of spontaneously immortalized granulosa cells and rat granulosa cells, Biol Reprod, 88, 20, 10.1095/biolreprod.112.103036 · DOI
  42. Pessin, 1999, Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!, J Biol Chem, 274, 2593, 10.1074/jbc.274.5.2593 · DOI
  43. Piel III, 2016, A novel role for progesterone receptor membrane component 1 (PGRMC1): a partner and regulator of ferrochelatase, Biochemistry, 55, 5204, 10.1021/acs.biochem.6b00756 · DOI
  44. Posner, 2017, Insulin signalling: the inside story, Can J Diabetes, 41, 108, 10.1016/j.jcjd.2016.07.002 · DOI
  45. Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, 414, 799, 10.1038/414799a · DOI · Paper page
  46. Sciacca, 2014, Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression, J Cell Physiol, 229, 1817, 10.1002/jcp.24635 · DOI
  47. Song, 2013, Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders, Nature, 494, 375, 10.1038/nature11834 · DOI
  48. Stöckli, 2011, GLUT4 exocytosis, J Cell Sci, 124, 4147, 10.1242/jcs.097063 · DOI
  49. Sun, 2016, Pgrmc1/BDNF signaling plays a critical role in mediating glia-neuron cross talk, Endocrinology, 157, 2067, 10.1210/en.2015-1610 · DOI
  50. Szczesna-Skorupa, 2011, Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase, Mol Pharmacol, 79, 340, 10.1124/mol.110.068478 · DOI
  51. Thomas, 2014, Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors, Endocrinology, 155, 1107, 10.1210/en.2013-1991 · DOI
  52. Tseng, 2013, LMBD1 protein serves as a specific adaptor for insulin receptor internalization, J Biol Chem, 288, 32424, 10.1074/jbc.M113.479527 · DOI
  53. Vincent, 2013, Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor, PLoS One, 8, 10.1371/journal.pone.0066963 · DOI
  54. Xu, 2011, Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site, Nat Commun, 2, 380, 10.1038/ncomms1386 · DOI · Paper page
  55. Zhang, 2014, Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells, Mol Cell Proteomics, 13, 3049, 10.1074/mcp.M114.040196 · DOI
  56. Zhao, 2007, Functional properties and genomics of glucose transporters, Curr Genomics, 8, 113, 10.2174/138920207780368187 · DOI

Cited by

Sorted by citations

See all 39

Metadata

Authors
Hampton, K. K., Anderson, K., Frazier, H., Thibault, O., & Craven, R. J.
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
2018-07
Volume
94
Issue
1
Pages
665-673
ISSN
0026-895X
DOI
10.1124/mol.117.110510
Cited by
39
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review